Cloud DX Appoints New Board Member

Neil Fraser, outgoing President of Medtronic Canada joins the board.

News in Summary:

• Cloud DX Inc. appoints Neil Fraser as an independent Board Director.
• Mr. Fraser is the just-retired former President of Medtronic Canada.
• Medtronic Canada and Cloud DX executed a partnership agreement in December 2021, and announced the new $12.8M. Continuous Connected Patient Care project on November 8, 2022.

KITCHENER, ON / ACCESSWIRE / November 15, 2022 / Cloud DX Inc. ("Cloud DX", or, the "Company") (TSXV:CDX)(OTC:CDXFF), a leading Canadian provider of virtual care and remote patient monitoring solutions today announced the appointment of Neil Fraser to the board as an independent director.

Mr. Fraser retired in July 2022 from his role as President of Medtronic Canada, a subsidiary of Medtronic plc, a global leader in healthcare technology. He is currently a board member of Sona Nanotech Inc. and a member of various health-related councils including the CD Howe Institute and the International Working Group on Global Research, Development & Innovation with the BRG Institute. In the past, he has acted as Chair of Medtech Canada, Board Member of Baycrest Health Sciences, Member of both the federal Advisory Panel on Healthcare Innovation (the "Naylor report") and the Ontario Health Innovation Council. Several of Neil's writings on the topic of healthcare innovation in Canada have been published, and he has frequently been invited to share his expertise on value-based procurement and outcomes-based healthcare innovation. In 2022, he was awarded the Distinguished Leader Award by the Canadian College of Health Leaders.

On December 1, 2021 Medtronic Canada and Cloud DX announced an exclusive Partnership Agreement under which the partners co-market Cloud DX Connected Health solutions to hospitals and health authorities across Canada. On February 23, 2022, the partners announced the first contract signed under the agreement with St. Mary's Hospital in Kitchener ON.

On November 8, 2022, Cloud DX announced the $12.8M Continuous Connected Patient Care (CCPC) project, in partnership with Medtronic plc along with a consortium of Canadian health technology leaders and academic institutions plus a $5.2M co-investment from the Digital Supercluster. The consortium will integrate novel sensors from Medtronic with the Cloud DX Connected Health platform, and then jointly distribute the combined technology around the world.

"We're extremely pleased to welcome Neil to our Board," says Cloud DX Founder, CEO and Board Chair Robert Kaul. "His leadership of Medtronic spans a period of tremendous growth and innovation in the Medical Technology industry. Neil's guidance and counsel on the Board will be critical to Cloud DX's success as we move into the next stage of our journey with our partners Medtronic, Teladoc Health and others. It's hard to imagine a better person to assist our team in fulfilling our mission to make healthcare better for everyone."

Mr. Fraser states, "I was very impressed with the team at Cloud DX during our partnership selection process. The company is delivering what we considered to be the best remote patient monitoring solution on the market today, and in addition, they have developed some remarkable new products that I believe will change outcomes and improve healthcare delivery all over the world. I'm honored to be invited to join the Board of Directors and I look forward to being part of the Cloud DX story going forward."

Mr. Fraser's appointment is subject to approval by the TSX Venture Exchange.

About Cloud DX
Accelerating digital healthcare, Cloud DX is on a mission to make healthcare better for everyone. Our Connected Health TM remote patient monitoring platform is used by healthcare enterprises and care teams across North America to virtually manage chronic disease, enable aging in place, and deliver hospital-quality post-surgical care in the home. Our partners achieve better healthcare and patient outcomes, reduce the need for hospitalization or re-admission, and reduce healthcare delivery costs through more efficient use of resources. Cloud DX is the co-winner of the Qualcomm Tricorder XPRIZE, 2022 Top Innovator by Canadian Business, a 2021 Edison Award winner, a Fast Company "World Changing Idea" finalist, and one of "Canada's Ten Most Prominent Telehealth Providers." Cloud DX is an exclusive partner to Medtronic, Teladoc Health, and Equitable Life of Canada.

Cloud DX will host its Q3 Earnings Calls November 16, 2022 at 12 PM Eastern Time, register here.

Cloud DX Investor Sitehttps://ir.clouddx.com/overview/default.aspx

_{Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.}

Social Links

Twitter https://twitter.com/CloudDX
Facebook https://www.facebook.com/clouddxinc/
LinkedIn https://www.linkedin.com/company/cloud-dx/
Instagram https://www.instagram.com/cloud.dx/

For media inquiries please contact:

Janine Scott
Marketing Lead
888-543-0944
janine.scott@CloudDX.com

For investor inquiries please contact:

Canada:
Jay Bedard
647-881-8418
jay.bedard@CloudDX.com

US:
Gary Zwetchkenbaum
516-455-7662
ir@CloudDX.com

Forward Looking Statements

This news release contains forward-looking statements and information within the meaning of applicable securities legislation. Often, but not always, forward-looking statements and information can be identified by the use of words such as "plans", "expects" or "does not expect", "is expected", "estimates", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Forward looking statements or information involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements or information contained in this news release. In particular, this news release includes certain forward-looking statements concerning the advancement of the Company's business and partnerships, the expected proceeds therefrom, regulatory approvals, as well as management's objectives, strategies, beliefs and intentions.

Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information. In making the forward-looking statements in this news release, the Company has applied several material assumptions, including without limitation, the Company's the ability of the Company to fulfill the terms of and derive the benefits from the contract extension.

Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information.

SOURCE: Cloud DX Inc.